SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-012525
Filing Date
2021-03-11
Accepted
2021-03-11 16:18:16
Documents
81
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K kzr-10k_20201231.htm   iXBRL 10-K 3135671
2 EX-10.9 kzr-ex109_8.htm EX-10.9 18589
3 EX-23.1 kzr-ex231_11.htm EX-23.1 3193
4 EX-31.1 kzr-ex311_7.htm EX-31.1 21502
5 EX-31.2 kzr-ex312_6.htm EX-31.2 21645
6 EX-32.1 kzr-ex321_12.htm EX-32.1 9201
7 GRAPHIC ggzs2zmnpwip000001.jpg GRAPHIC 141052
  Complete submission text file 0001564590-21-012525.txt   10830949

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA kzr-20201231.xsd EX-101.SCH 65490
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kzr-20201231_cal.xml EX-101.CAL 53412
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kzr-20201231_def.xml EX-101.DEF 180341
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE kzr-20201231_lab.xml EX-101.LAB 495871
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kzr-20201231_pre.xml EX-101.PRE 368208
13 EXTRACTED XBRL INSTANCE DOCUMENT kzr-10k_20201231_htm.xml XML 2027386
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38542 | Film No.: 21733533
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences